Effects of Peppermint Oil in Cardiometabolic Outcomes
Effects of Oral Peppermint Supplementation on Cardiometabolic Parameters
Sponsor: University of Central Lancashire
This NA trial investigates Cardiometabolic Syndrome and is currently completed. University of Central Lancashire leads this study, which shows 8 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Sep 2022 — Apr 2023 [monthly]
Recruiting NA
-
Apr 2022 — Sep 2022 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Feb 2022 — Apr 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2022 — Feb 2022 [monthly]
Not Yet Recruiting NA
-
Nov 2021 — Jan 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Central Lancashire
For direct contact, visit the study record on ClinicalTrials.gov .